PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
StakeholdersMedia, Education & EngagementMedia & CommunicationGeneral Media Outlets
6 Organisations

General Media Outlets

Mainstream media outlets covering psychedelic developments — newspapers, TV, and general-interest publications.

Organisations
6

All Organisations

BBC News

Public-service international news organization with recurring coverage of psychedelic clinical evidence, regulation, and public-health implications.

View Profile

NPR

U.S. public media network with recurring psychedelic reporting across science, health, policy, and patient-outcome narratives.

View Profile

TIME

Mainstream international magazine with repeated long-form and news coverage on psychedelic medicine development and policy shifts.

View Profile

The Guardian

Global general-news outlet with sustained reporting and commentary on psychedelic science, policy reform, safety, and cultural adoption.

View Profile

The Washington Post

Major U.S. news publication with ongoing reporting on psychedelic health research, therapeutic access, legal frameworks, and safety concerns.

View Profile

VICE

Digital-first global media brand with extensive psychedelic-focused journalism spanning science explainers, policy analysis, and culture reporting.

View Profile

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.